Loading clinical trials...
Loading clinical trials...
The study aims to identify predictors of disease in patients with hyperparathyroidism (HPTH) who undergo surgery.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
M.D. Anderson Cancer Center
NCT07165886 · Gastroenteropancreatic Neuroendocrine Tumors
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07536087 · Endoscopic Ultrasound-Guided Radiofrequency Ablation, Pancreatic Neuroendocrine Tumors (pNET), and more
NCT03969329 · Secondary Hyperparathyroidism
NCT03633708 · Secondary Hyperparathyroidism, Chronic Kidney Disease
University of Texas MD Anderson Cancer Center
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions